United States News Todas as matérias

Blackstone (NYSE:BX) and Alphabet Google (NYSE:GOOGL) have agreed to establish a new independent, U.S.-based technology company designed to expand enterprise access to artificial intelligence infrastructure and specialized semiconductor capacity.

CMB.TECH (NYSE:CMBT) reported a substantial increase in first-quarter profitability and revenue, boosted by elevated spot rates across major commercial shipping routes and significant capital gains from its asset disposal strategy.

ATRenew (NYSE:RERE) reported a significant acceleration in profitability for the first quarter of 2026, driven by robust top-line momentum and expanded margins across its pre-owned consumer electronics transaction platforms.

Bally’s Corp. (NYSE:BALY) reported a 28.3% surge in first-quarter revenue, hitting $755.7 million for the period ended March 31, 2026.

Agilysys (NASDAQ:AGYS) reported its financial results for the fiscal 2026 fourth quarter ended March 31, 2026, securing its 17th consecutive quarter of record-breaking top-line results.

CBAK Energy Technology (NASDAQ:CBAT) reported its unaudited financial results for the first quarter ended March 31, 2026, delivering an explosive near-doubling of its top-line revenue.

Ryanair Holdings plc (NASDAQ:RYAAY) reported its finalized, record-breaking financial results for the fiscal year ended March 31, 2026 (FY26), highlighting explosive bottom-line performance, strategic fuel defenses, and significant corporate restructuring.

Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) announced positive chemistry, manufacturing, and controls (CMC) data supporting the late-stage development of its lead antimicrobial candidate, Nu-3.

C3is (NASDAQ:CISS) announced its financial and operational results for the first quarter ended March 31, 2026, delivering substantial bottom-line expansion and enhanced operating leverage.

INNEOVA Holdings (NASDAQ:INEO) announced its audited financial results for the fiscal year ended December 31, 2025, charting a period of transition and operational realignment.

Design Therapeutics (NASDAQ:DSGN) announced positive biomarker and clinical findings from its ongoing Phase 1/2 RESTORE-FA clinical trial evaluating DT-216P2 in individuals with Friedreich ataxia (FA).

Brady Corporation (NYSE:BRC) reported its financial results for the fiscal 2026 third quarter ended April 30, 2026, delivering substantial top-line acceleration and record-setting profitability metrics.

AstraZeneca (NASDAQ:AZN) announced that the U.S. Food and Drug Administration (FDA) has approved BAXFENDY™ (baxdrostat) for the treatment of hypertension in adults.

WeTouch Technology (NASDAQ:WETH) reported its unaudited financial results for the first quarter ended March 31, 2026, delivering significant bottom-line acceleration and stable revenue growth.

NextEra Energy (NYSE:NEE) announced Monday a definitive agreement to acquire Dominion Energy (NYSE:D) in an all-stock transaction valued at approximately $67 billion.

Ondas Holdings (NASDAQ:ONDS) has signed a definitive agreement to acquire 100% of Omnisys, an Israeli-based developer of advanced, AI-powered Battle Resource Optimization (BRO) software.

Silexion Therapeutics (NASDAQ:SLXN) reported its financial results for the first quarter ended March 31, 2026, alongside corporate updates highlighting the regulatory progression of its lead RNA interference (RNAi) asset, SIL204.

SOL Strategies (NASDAQ:STKE) announced its financial results for the fiscal second quarter ended March 31, 2026, showcasing strong infrastructure scaling across its validation network despite a localized impact from cryptocurrency price swings.

Scienture Holdings (NASDAQ:SCNX) reported its financial results for the first quarter ended March 31, 2026, delivering dramatic top-line acceleration and margin optimization alongside key regulatory and pipeline updates.

NervGen Pharma (NASDAQ:NGEN) reported its financial results and operational updates for the first quarter ended March 31, 2026, highlighting clinical milestones for its lead compound and its recent successful transition to a major U.S. exchange.

Elanco Animal Health (NYSE:ELAN) has announced the phased U.S. launch of Befrena (tirnovetmab), a new anti-IL-31 monoclonal antibody (mAb) injectable solution indicated for the treatment of canine allergic and atopic dermatitis.

Functional Brands (NASDAQ:MEHA) reported its financial results for the first quarter ended March 31, 2026, delivering top-line growth and a notable expansion in product margins alongside a series of digital and corporate transitions.

Core AI Holdings (NASDAQ:CHAI) reported its financial results for the fiscal year ended December 31, 2025, highlighting a transitional period marked by strong top-line growth from its ongoing digital platforms and a total restructuring of its operational model.

SHF Holdings, doing business as Safe Harbor Financial (NASDAQ:SHFS), reported its financial results for the first quarter ended March 31, 2026, showcasing a dramatic turnaround in its underlying balance sheet health and a solid expansion of its core credit verticals.